Example: Heart Attack

Clinical Trials on High-Risk Resectable Pancreatic Cancer

Total 5535 results

NCT07833241

Not yet recruiting

Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC (ZSPAC-22)

Borderline Resectable Pancreatic Cancer | High-Risk Resectable Pancreatic Cancer
NCT07682272

Not yet recruiting

A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk
NCT07539155

Recruiting

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Borderline Resectable/Unresectable Pancreatic Cancer | Non Metastatic Pancreatic Cancer
NCT05013216

Active, not recruiting

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Pancreatic Cancer | High Risk Cancer
NCT04698915

Terminated

Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

Unresectable Pancreatic Cancer | Borderline Resectable Pancreatic Cancer | SBRT

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register